Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 61.81B | 62.03B | 58.97B | 46.73B | 40.51B | 38.18B |
Gross Profit | 8.23B | 8.18B | 7.62B | 6.64B | 6.29B | 5.60B |
EBITDA | 1.75B | 2.40B | 2.00B | 1.46B | 1.32B | 692.00M |
Net Income | 1.10B | 1.05B | 792.19M | 532.65M | 469.77M | 99.00M |
Balance Sheet | ||||||
Total Assets | 37.00B | 36.68B | 36.17B | 30.85B | 27.14B | 26.24B |
Cash, Cash Equivalents and Short-Term Investments | 5.33B | 5.30B | 5.19B | 4.26B | 4.83B | 3.72B |
Total Debt | 10.79B | 11.02B | 12.13B | 8.95B | 7.67B | 8.06B |
Total Liabilities | 23.56B | 23.44B | 22.87B | 18.09B | 14.93B | 14.35B |
Stockholders Equity | 11.81B | 11.62B | 10.52B | 10.06B | 9.49B | 8.35B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 3.40B | -2.12B | -1.35B | 1.97B | -467.06M |
Operating Cash Flow | 0.00 | 3.81B | -1.29B | -731.44M | 2.26B | 254.53M |
Investing Cash Flow | 0.00 | -797.00M | -713.22M | -661.16M | -266.11M | -767.11M |
Financing Cash Flow | 0.00 | -2.93B | 2.94B | 798.91M | -882.49M | -226.88M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $1.24T | 19.77 | 12.17% | 1.71% | 7.29% | 9.73% | |
74 Outperform | ¥8.69B | 9.85 | 2.66% | 1.50% | -15.50% | ||
74 Outperform | ¥3.89T | 55.73 | 8.89% | 2.06% | 6.35% | -17.08% | |
73 Outperform | $924.15B | 14.45 | 13.14% | 2.65% | 3.80% | 14.95% | |
72 Outperform | $275.50B | 21.44 | 4.20% | 1.70% | 5.28% | -26.90% | |
71 Outperform | €541.98B | 19.56 | 9.37% | 0.26% | 5.82% | 32.64% | |
68 Neutral | ¥196.02B | 22.33 | 8.29% | 2.30% | 5.00% | 1.16% |